Literature DB >> 12637842

Treatment preferences and determinants in victims of sexual and physical assault.

Peter Roy-Byrne1, Lucy Berliner, Joan Russo, Douglas Zatzick, Roger K Pitman.   

Abstract

To determine the treatment preferences (, medication, counseling, or both) for victims of recent trauma at risk for posttraumatic stress disorder and the determinants of those choices, preferences were elicited from 466 consecutive victims of physical or sexual assault at an urban emergency department as part of the routine clinical evaluation by emergency department social workers. Demographics, assault characteristics, and clinical history were used to predict preference. More than 80% of victims expressed an interest in treatment, with more interested in counseling (76%) than medication (62%). Female gender and assaults of a sexual nature were most highly predictive of preference for medication, whereas female gender, sexual assault, a history of psychiatric treatment, and perceived life threat from the trauma were most predictive of preference for counseling and preference for any treatment. Because treatment preferences were easily obtained from assault victims seeking emergency care, the elicitation of these treatment preferences and the consideration of them in the treatment planning process could facilitate engagement in treatment and overcome the avoidance of treatment by some victims.

Entities:  

Mesh:

Year:  2003        PMID: 12637842     DOI: 10.1097/01.NMD.0000055343.62310.73

Source DB:  PubMed          Journal:  J Nerv Ment Dis        ISSN: 0022-3018            Impact factor:   2.254


  16 in total

1.  Do You Need To Talk About It? Prolonged Exposure for the Treatment of Chronic PTSD.

Authors:  Afsoon Eftekhari; Lisa R Stines; Lori A Zoellner
Journal:  Behav Anal Today       Date:  2006-01-01

2.  Alterations in stress reactivity after long-term treatment with paroxetine in women with posttraumatic stress disorder.

Authors:  Eric Vermetten; Meena Vythilingam; Christian Schmahl; Carien DE Kloet; Steven M Southwick; Dennis S Charney; J Douglas Bremner
Journal:  Ann N Y Acad Sci       Date:  2006-07       Impact factor: 5.691

3.  Patient preferences for obsessive-compulsive disorder treatment.

Authors:  Sapana R Patel; Helen Blair Simpson
Journal:  J Clin Psychiatry       Date:  2010-11       Impact factor: 4.384

4.  Unique Ethical Concerns in Clinical Trials Comparing Psychosocial and Psychopharmalogical Interventions.

Authors:  Lisa R Stines; Norah C Feeny
Journal:  Ethics Behav       Date:  2008

5.  PTSD and Problem Drinking in Relation to Seeking Mental Health and Substance Use Treatment Among Sexual Assault Survivors.

Authors:  Anne Kirkner; Mark Relyea; Sarah E Ullman
Journal:  Traumatology (Tallahass Fla)       Date:  2017-08-10

6.  Reasons underlying treatment preference: an exploratory study.

Authors:  Bryan N Cochran; Larry Pruitt; Seiya Fukuda; Lori A Zoellner; Norah C Feeny
Journal:  J Interpers Violence       Date:  2008-02

7.  Providing a treatment rationale for PTSD: does what we say matter?

Authors:  Norah C Feeny; Lori A Zoellner; Shoshana Y Kahana
Journal:  Behav Res Ther       Date:  2009-06-21

8.  What you believe is what you want: modeling PTSD-related treatment preferences for sertraline or prolonged exposure.

Authors:  Lori A Zoellner; Norah C Feeny; Joyce N Bittinger
Journal:  J Behav Ther Exp Psychiatry       Date:  2009-06-12

9.  "How will it help me?" Reasons underlying treatment preferences between sertraline and prolonged exposure in posttraumatic stress disorder.

Authors:  Jessica A Chen; Stephanie M Keller; Lori A Zoellner; Norah C Feeny
Journal:  J Nerv Ment Dis       Date:  2013-08       Impact factor: 2.254

10.  The effects of positive patient testimonials on PTSD treatment choice.

Authors:  Larry D Pruitt; Lori A Zoellner; Norah C Feeny; Daniel Caldwell; Robert Hanson
Journal:  Behav Res Ther       Date:  2012-10-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.